Tetravalent etanercept
View Patent ↗Disclosed are concatameric proteins comprising two soluble domains, in which the C-terminus of a soluble domain of a biologically active protein is linked to the N-terminus of an identical soluble domain or a distinct soluble domain of a biologically active protein. Also, the present invention discloses dimeric proteins formed by formation of intermolecular disulfide bonds at the hinge region of two monomeric proteins formed by linkage of a concatamer of two identical soluble extracellular regions of proteins involving immune response to an Fc fragment of an immunoglobulin molecule, their glycosylated proteins, DNA constructs encoding the monomeric proteins, recombinant expression plasmids containing the DNA construct, host cells transformed or transfected with the recombinant expression plasmids, and a method of preparing the dimeric proteins by culturing the host cells. Further, the present invention discloses pharmaceutical or diagnostic compositions comprising the dimeric protein or its glycosylated form.
1. A dimeric protein comprising two monomeric subunits, each monomeric subunit comprising a concatamer of two identical soluble extracellular domains of a TNFR2 receptor protein, linked to a Fc fragment of an immunoglobulin molecule comprising a hinge region of the immunoglobulin molecule, wherein said monomeric subunits are linked by disulfide bonds at their respective hinge regions; and wherein the monomeric subunit comprises the amino acid sequence of SEQ ID NO:8.
2. The dimeric protein as set forth in claim 1 , wherein the immunoglobulin molecule is IgG.
3. A pharmaceutical composition comprising the dimeric protein of claim 1 .